Abstract:Introduction Aortic valve stenosis (AS) is the most prevalent valvular heart disease and constitutes a major public health issue. Endothelial injury is an early event that might play a significant role in the setting of calcific deposits leading to AS. Assessment of endothelial dysfunction may therefore be of interest in the assessment AS. Objective Angiopoietin-2 (Ang-2) is a factor secreted by endothelial cells that have gained attention in recent years as potential biomarkers of endothelial injury. Our study aims to evaluate the usefulness of circulating Ang-2 for diagnosis and progression of AS. Method The prospective COFRASA/GENERAC cohort was used for this study which focuses on 208 asymptomatic AS patients with a tricuspid valve. At baseline and yearly thereafter, patients underwent clinical examination, blood measurement, transthoracic echocardiography (TTE), and multi-slice computed tomography (MSCT). Serum was used to measure Ang-2 concentration using an immunoassay commercial kit. Disease severity was assessed using a combination of the usual haemodynamic and morphological TTE parameters ie mean pressure gradient (MPG), peak transvalvular velocity (PV) aortic valve area (AVA) and aortic valve calcification (AVC) by MSCT. Progression was defined as the mean annual increase in either MPG, PV, AVA and AVC and rapid progression as a progression higher than the cohort's median progression for each parameter. Results Serum Ang-2 concentrations were significantly higher in AS patients as compared to a healthy control group ( P < 0.0001) and were also higher in the severe AS group as compared to moderate AS or mild AS groups ( P < 0.05). Independent association of Ang-2 with progression of MPG, PV, and AVC was shown through multivariate analysis using Cox proportional hazards ratio ( P < 0.001). ROC curve analysis identified a possible Ang-2 serum threshold of 3.89 ng/mL. AS patients were then separated in 2 groups and LogRank analysis of Kaplan-Meier curves showed patients with Ang-2 higher than 3.89 ng/mL progressed more rapidly than their counterparts ( P < 0.05). Conclusion These results suggest that Ang-2 could be a useful parameter to consider when evaluating AS patients' severity and risk for rapid progression, in conjunction with traditional criteria. However, further studies are needed to corroborate our findings and determine clinical use.

Serum lncRNA RAMP2-AS1 Served as a Biomarker of Deep Vein Thrombosis Occurrence and Development in Elderly

Relationship Between Endothelial Cell Protein C Receptor Gene 6936A/G Polymorphisms and Deep Venous Thrombosis.

Assessing the Risk for Development of Deep Vein Thrombosis among Chinese Patients Using the 2010 Caprini Risk Assessment Model: A Prospective Multicenter Study.

RAMP2-AS1 Regulates Endothelial Homeostasis and Aging

LncRNA Sirt1-AS upregulates Sirt1 to attenuate aging related deep venous thrombosis

ELISA for aging biomarkers induced by telomere dysfunction in human plasma.

LncRNA NEAT1 Promotes Vascular Endothelial Cell Dysfunction via miR-218-5p/GAB2 and Serves as a Diagnostic Biomarker for Deep Vein Thrombosis

Clinical significance and underlying mechanism of long non‐coding RNA SNHG12 in lower extremity deep venous thrombosis

LncRNA GUSBP5-AS promotes EPC migration and angiogenesis and deep vein thrombosis resolution by regulating FGF2 and MMP2/9 through the miR-223-3p/FOXO1/Akt pathway

Long Noncoding Rna Expression Profile Of Endothelial Progenitor Cells From Deep Vein Thrombosis Patients Identified By Microarray Analysis

Mir-21 Induces Endothelial Progenitor Cells Proliferation and Angiogenesis Via Targeting FASLG and is a Potential Prognostic Marker in Deep Venous Thrombosis

Abnormal expression of long non-coding RNA rhabdomyosarcoma 2-associated transcript (RMST) participates in the pathological mechanism of atherosclerosis by regulating miR-224-3p

A Panel of Micrornas As a New Biomarkers for the Detection of Deep Vein Thrombosis

Non-coding RNAs regulating endothelial progenitor cells for venous thrombosis: promising therapy and innovation

Age-adjusted D-Dimer Thresholds Combined with the Modified Wells Score as a Predictor of Lower Extremity Deep Venous Thrombosis

Identification of novel biomarkers for atherosclerosis using single-cell RNA sequencing and machine learning

Hsa_circ_0001020 accelerates the lower extremity deep vein thrombosis via sponging miR-29c-3p to promote MDM2 expression

Significance of Serum Angiopoietin-Like Protein 2 in the Occurrence and Progression of Diabetic Kidney Disease: A Cross-Sectional Study

Angiopoietin-2 as a potential biomarker predictive of aortic valve stenosis progression

LncRNA WTAPP1 Promotes Migration and Angiogenesis of Endothelial Progenitor Cells via MMP1 Through MicroRNA 3120 and Akt/PI3K/Autophagy Pathways

Serum PLA2R antibody as a predictive biomarker for venous thromboembolism risk in primary membranous nephropathy